Exploration of safety indicators for radiotherapy in hepatocellular carcinoma: A real-world study.
EBRT is safe and effective for HCC patients at different stages. Compared with MLD and RLV, rRFLV<sub>x</sub> and rRFLV<sub>x</sub>/SLV may be more reliable for evaluating the occurrence of RILDs after IMRT treatment. For patients with hepatitis background, concurrent antiviral therapy during radiotherapy is relatively safe, but serum viral load should be closely monitored. Further research is needed to explore the efficacy and safety of radiotherapy combined with targeted and immunotherapy.
Authors
- H. P. Peng
- Qiao Jin
- Xuan Xie (ORCID: https://orcid.org/0000-0001-5275-964X)
- Xi Zhang (ORCID: https://orcid.org/0000-0002-0422-8980)
- Peiguo Cao (ORCID: https://orcid.org/0000-0001-7274-3071)
- Zhen Zhang
- Yuliang Pan
- Jun Zhang
Institutions
- Central South University (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-10-28
- DOI
- https://doi.org/10.11817/j.issn.1672-7347.2025.250218
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00